ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Antiviral Activity of IDX184 in Combination With Pegylated Interferon and Ribavirin (MK-2355-004)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01011166
Recruitment Status : Completed
First Posted : November 11, 2009
Last Update Posted : April 23, 2015
Sponsor:
Information provided by (Responsible Party):
Merck Sharp & Dohme Corp.